Membrane-targeting AM-0016 kills mycobacterial persisters and shows low propensity for resistance development

Future Microbiol. 2016 May:11:643-50. doi: 10.2217/fmb-2015-0015. Epub 2016 May 9.

Abstract

Aim: To test the hypothesis that targeting the cytoplasmic membrane may be an effective way to kill persister mycobacteria and delay the emergence of resistance.

Methods: In vitro activity of AM-0016, a novel xanthone-based antibacterial, was assessed against growing and persister tubercle bacilli. Resistance mutation frequencies were determined. Biochemical membrane and electron microscopic analyses were carried out.

Results: AM-0016 rapidly sterilized growing tubercle bacillus cultures and displayed strong bactericidal activity against persister bacteria. Spontaneous resistance mutation frequency was lower than 10(-8). Exposure to AM-0016 resulted in rapid collapse of the membrane potential. Imaging revealed deformation of the cell envelope.

Conclusion: Targeting the cytoplasmic membrane may be an attractive approach to eliminate persister mycobacteria and slow down the emergence of genetic drug resistance.

Keywords: drug resistance; drug tolerance; tuberculosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology*
  • Cell Membrane / drug effects*
  • Drug Resistance, Bacterial
  • Membrane Potentials / drug effects
  • Microbial Sensitivity Tests
  • Microbial Viability / drug effects
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / growth & development*
  • Xanthones / chemistry
  • Xanthones / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Xanthones
  • xanthone